Literature DB >> 4633302

Rh prevention: a report and analysis of a national programme.

J Eklund, H R Nevanlinna.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4633302      PMCID: PMC1012966          DOI: 10.1136/jmg.10.1.1

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  8 in total

1.  The pathogenesis and prevention of Rh immunization.

Authors:  A Zipursky; L G Israels
Journal:  Can Med Assoc J       Date:  1967-11-18       Impact factor: 8.262

2.  Blood group incompatibility between mother and foetus.

Authors:  C A Clarke
Journal:  Clin Sci       Date:  1972-07       Impact factor: 6.124

3.  Significance of Rh-sensitization during pregnancy: its relation to a preventive programme.

Authors:  J C Godel; D I Buchanan; J M Jarosch; M McHugh
Journal:  Br Med J       Date:  1968-11-23

4.  Rh-immunization by pregnancy: results of a survey and their relevance to prophylactic therapy.

Authors:  J C Woodrow; W T Donohoe
Journal:  Br Med J       Date:  1968-10-19

5.  Use of different doses of anti-Rh IgG in the prevention of Rh isoimmunisation.

Authors:  D I Buchanan; R E Bell; R P Beck; W C Taylor
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

6.  Prevention of haemolytic disease of the newborn.

Authors:  J M Bowman
Journal:  Br J Haematol       Date:  1970-12       Impact factor: 6.998

7.  Incidence of maternal Rh immunization by ABO compatible and incompatible pregnancies.

Authors:  W Q Ascari; P Levine; W Pollack
Journal:  Br Med J       Date:  1969-02-15

8.  Prevention of Rh-haemolytic disease: results of the Liverpool "low-risk" clinical trial.

Authors:  J C Woodrow; C A Clarke; R B McConnell; S H Towers; W T Donohoe
Journal:  Br Med J       Date:  1971-06-12
  8 in total
  3 in total

1.  Transplacental passage of blood cells.

Authors:  J Schröder
Journal:  J Med Genet       Date:  1975-09       Impact factor: 6.318

2.  The decline in Rh hemolytic disease: should Rh prophylaxis get all the credit?

Authors:  K S Joseph; M S Kramer
Journal:  Am J Public Health       Date:  1998-02       Impact factor: 9.308

3.  Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy.

Authors: 
Journal:  Br Med J       Date:  1974-04-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.